Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review

被引:8
作者
Tsigkas, Grigorios [1 ]
Vakka, Angeliki [1 ]
Apostolos, Anastasios [1 ,2 ]
Bousoula, Eleni [3 ]
Vythoulkas-Biotis, Nikolaos [1 ]
Koufou, Eleni-Evangelia [1 ]
Vasilagkos, Georgios [1 ]
Tsiafoutis, Ioannis [4 ]
Hamilos, Michalis [5 ]
Aminian, Adel [6 ]
Davlouros, Periklis [1 ]
机构
[1] Univ Hosp Patras, Dept Cardiol, Patras 26504, Greece
[2] Natl & Kapodistrian Univ Athens, Hippocrat Gen Hosp, Dept Cardiol 1, Athens 15772, Greece
[3] Tzaneio Gen Hosp, Dept Cardiol, Piraeus 18536, Greece
[4] Red Cross Hosp, Dept Cardiol 1, Athens 11526, Greece
[5] Heraklion Univ Hosp, Dept Cardiol, Iraklion 71500, Crete, Greece
[6] Ctr Hospitalier Univ Charleroi, Dept Cardiol, B-6042 Charleroi, Belgium
关键词
cancer; acute coronary syndrome (ACS); percutaneous coronary intervention (PCI); dual antiplatelet therapy (DAPT); triple antithrombotic therapy (TAT); atrial fibrillation (AF); cardiotoxicity; PERCUTANEOUS CORONARY INTERVENTION; PATENT FORAMEN OVALE; ANTITHROMBOTIC THERAPY; ANTICOAGULANT TREATMENT; ATRIAL-FIBRILLATION; OUTCOMES; DISEASE; CLOSURE; STROKE; BREAST;
D O I
10.3390/jcdd10040135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular (CV) events in patients with cancer can be caused by concomitant CV risk factors, cancer itself, and anticancer therapy. Since malignancy can dysregulate the hemostatic system, predisposing cancer patients to both thrombosis and hemorrhage, the administration of dual antiplatelet therapy (DAPT) to patients with cancer who suffer from acute coronary syndrome (ACS) or undergo percutaneous coronary intervention (PCI) is a clinical challenge to cardiologists. Apart from PCI and ACS, other structural interventions, such as TAVR, PFO-ASD closure, and LAA occlusion, and non-cardiac diseases, such as PAD and CVAs, may require DAPT. The aim of the present review is to review the current literature on the optimal antiplatelet therapy and duration of DAPT for oncologic patients, in order to reduce both the ischemic and bleeding risk in this high-risk population.
引用
收藏
页数:16
相关论文
共 50 条
[41]   Major Bleeding after Surgical Revascularization with Dual Antiplatelet Therapy [J].
Schlachtenberger, Georg ;
Deppe, Antje Christin ;
Gerfer, Stephen ;
Choi, Yeong-Hoon ;
Zeriouh, Mohamed ;
Liakopoulos, Oliver ;
Wahlers, Thorsten C. W. .
THORACIC AND CARDIOVASCULAR SURGEON, 2020, 68 (08) :714-722
[42]   Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study [J].
Foschi, Matteo ;
De Santis, Federico ;
D'Anna, Lucio ;
Romoli, Michele ;
Tassinari, Tiziana ;
Saia, Valentina ;
Cenciarelli, Silvia ;
Bedetti, Chiara ;
Padiglioni, Chiara ;
Censori, Bruno ;
Puglisi, Valentina ;
Vinciguerra, Luisa ;
Guarino, Maria ;
Barone, Valentina ;
Zedde, Marialuisa ;
Grisendi, Ilaria ;
Diomedi, Marina ;
Bagnato, Maria Rosaria ;
Petruzzellis, Marco ;
Mezzapesa, Domenico Maria ;
Inchingolo, Vincenzo ;
Cappellari, Manuel ;
Zivelonghi, Cecilia ;
Candelaresi, Paolo ;
Andreone, Vincenzo ;
Rinaldi, Giuseppe ;
Bavaro, Alessandra ;
Cavallini, Anna Maria ;
Piscaglia, Maria Grazia ;
Terruso, Valeria ;
Mannino, Marina ;
Pezzini, Alessandro ;
Frisullo, Giovanni ;
Muscia, Francesco ;
Paciaroni, Maurizio ;
Mosconi, Maria Giulia ;
Zini, Andrea ;
Leone, Ruggiero ;
Palmieri, Carmela ;
Cupini, Letizia Maria ;
Marcon, Michela ;
Tassi, Rossana ;
Sanzaro, Enzo ;
Papiri, Giulio ;
Viticchi, Giovanna ;
Orsucci, Daniele ;
Falcou, Anne ;
Diamanti, Susanna ;
Tarletti, Roberto ;
Nencini, Patrizia .
EUROPEAN STROKE JOURNAL, 2025,
[43]   Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis [J].
Shpigelman, Jonathan ;
Proshkina, Anastasia ;
Daly, Michael J. ;
Cox, Dermot .
CURRENT CARDIOLOGY REPORTS, 2023, 25 (07) :693-710
[44]   Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis [J].
Jonathan Shpigelman ;
Anastasia Proshkina ;
Michael J. Daly ;
Dermot Cox .
Current Cardiology Reports, 2023, 25 :693-710
[45]   Dual Antiplatelet Therapy Duration: A Review of Current Available Evidence [J].
Mastoris, Ioannis ;
Mathias, Priyanka Maria ;
Dangas, George D. .
CLINICAL THERAPEUTICS, 2016, 38 (04) :961-973
[46]   Prevalence of bleeding in patients on single or dual antiplatelet therapy combined with vitamin K antagonists or direct oral anticoagulants [J].
Alkhushaym, Nasser ;
Aldhafeeri, Maha ;
Hamad, Meshaal ;
Almutairi, Bander ;
Mahmud, Mamun ;
Alenizi, Maha ;
Alsalman, Abdulkhaliq J. .
INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2025, 36 (02) :78-84
[47]   Dual Antiplatelet Therapy: A Concise Review for Clinicians [J].
Virk, Hafeez Ul Hassan ;
Escobar, Johao ;
Rodriguez, Mario ;
Bates, Eric R. ;
Khalid, Umair ;
Jneid, Hani ;
Birnbaum, Yochai ;
Levine, Glenn N. ;
Smith Jr, Sidney C. ;
Krittanawong, Chayakrit .
LIFE-BASEL, 2023, 13 (07)
[48]   Comparison of Ischemic and Bleeding Events After Drug-Eluting Stents or Bare Metal Stents in Subjects Receiving Dual Antiplatelet Therapy: Results from the Randomized Dual Antiplatelet Therapy Study [J].
Kereiakes, Dean J. ;
Yeh, Robert J. ;
Massaro, Joseph M. ;
Driscoll-Shempp, Priscilla ;
Cutlip, Donald E. ;
Normand, Sharon-Lise T. ;
Steg, Philippe G. ;
Gershlick, Anthony H. ;
Tanguay, Jean-Francois ;
Windecker, Stephan ;
Garratt, Kirk N. ;
Kandzari, David E. ;
Lee, David P. ;
Simon, Daniel I. ;
Iancu, Adrian ;
Trebacz, Jaroslaw ;
Mauri, Laura .
CIRCULATION, 2014, 130 (23) :2113-2113
[49]   Dual Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease [J].
Keach, Joseph Walker ;
Yeh, Robert W. ;
Maddox, Thomas M. .
CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (01)
[50]   Dual antiplatelet treatment in TIA and high-risk ischemic CVA, a review of the POINT trial [J].
Hull, Margaret .
CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2020, 22 (01) :29-30